skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Dendritic Cell-gp100-MART-1 Antigen Vaccine (Code C2214)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Dendritic Cell-gp100-MART-1 Antigen Vaccine

Definition: An autologous dendritic cells vaccine with antineoplastic property. Dendritic cells harvested from cancer patients are pulsed with human gp100 melanoma antigen and MART-1 (melanoma antigen recognized by T-cells) antigen; both antigens are up-regulated in melanomas. Vaccination with this vaccine may elicit the host immune response against MART-1 or gp100 expressing cells.

Label: Dendritic Cell-gp100-MART-1 Antigen Vaccine

NCI Thesaurus Code: C2214 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0879263  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Dendritic Cell-gp100-MART-1 Antigen Vaccine
gp100/Mart-1-transduced dendritic cell vaccine

External Source Codes: 
PDQ Closed Trial Search ID 43549
PDQ Open Trial Search ID 43549 (check for NCI PDQ open clinical trial info)
UMLS CUI C0879263

Other Properties:
     Name Value (qualifiers indented underneath)
code C2214
Legacy_Concept_Name Dendritic_Cell-gp100-MART-1_Antigen_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom